Positron Corporation (POSC)
| Market Cap | 29.89M |
| Revenue (ttm) | 1.24M |
| Net Income (ttm) | -1.27M |
| Shares Out | 26.93M |
| EPS (ttm) | -0.09 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 21,354 |
| Average Volume | 15,416 |
| Open | 0.990 |
| Previous Close | 1.030 |
| Day's Range | 0.940 - 1.090 |
| 52-Week Range | 0.881 - 1.500 |
| Beta | 0.52 |
| RSI | 57.04 |
| Earnings Date | n/a |
About Positron
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York. [Read more]
Financial Performance
In 2014, Positron's revenue was $1.47 million, a decrease of -10.06% compared to the previous year's $1.63 million. Losses were -$2.58 million, -63.63% less than in 2013.
Financial StatementsNews
Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO
CHALK RIVER, Ontario--(BUSINESS WIRE)--Actineer, a joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., today announced the appointment of Joseph Oliverio as President and Chief Exe...
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
Niagara Falls, NY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Launches Prime Rental Program for Pet-Ct Systems
Niagara Falls, NY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Announces Sale of NeuSight PET-CT Scanner
Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT
Niagara Falls, NY, July 25, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET & PET-CT imaging sy...
Positron Corporation Orders 5 NeuSight PET-CT Scanners for US Market
Niagara Falls, NY, June 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Announces Attrius® PET System Sale
Niagara Falls, NY, June 18, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)
Niagara Falls, NY, June 14, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Enters OEM Supply and Distribution Agreement for NeuSight PET-CT 64 Slice Scanner
Niagara Falls, NY, June 13, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT
Niagara Falls, NY, June 12, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device
Niagara Falls, NY, July 21, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that the...
Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device
Niagara Falls, NY, March 01, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a molecular imaging device company that offers PET imaging systems and clinical se...
Positron Corporation Announces Plans for Clinical Study of its New “Affinity PET-CT 4D” Nuclear Imaging Device
Niagara Falls, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging systems and clinical services company, is pleased to...
Positron Corporation Announces First Step in Validation of its New PET-CT Device
Niagara Falls, NY, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is ple...
Positron Corporation Announces Key Sales & Services Personnel Hire
Niagara Falls, NY, June 24, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging device systems and clinical services company, is ple...